ATE240321T1 - 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität - Google Patents

4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität

Info

Publication number
ATE240321T1
ATE240321T1 AT97919907T AT97919907T ATE240321T1 AT E240321 T1 ATE240321 T1 AT E240321T1 AT 97919907 T AT97919907 T AT 97919907T AT 97919907 T AT97919907 T AT 97919907T AT E240321 T1 ATE240321 T1 AT E240321T1
Authority
AT
Austria
Prior art keywords
methyl
thien
alpha2
imidazole derivatives
agonistic activity
Prior art date
Application number
AT97919907T
Other languages
English (en)
Inventor
Robert E Boyd
Chris Royce Rasmussen
Jeffrey B Press
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE240321T1 publication Critical patent/ATE240321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97919907T 1996-03-28 1997-03-26 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität ATE240321T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/625,442 US5750720A (en) 1996-03-28 1996-03-28 4- (thien-3-yl)methyl!-imidazole analgesics
PCT/US1997/004773 WO1997035858A1 (en) 1996-03-28 1997-03-26 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY

Publications (1)

Publication Number Publication Date
ATE240321T1 true ATE240321T1 (de) 2003-05-15

Family

ID=24506097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919907T ATE240321T1 (de) 1996-03-28 1997-03-26 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität

Country Status (14)

Country Link
US (1) US5750720A (de)
EP (1) EP0954521B1 (de)
JP (1) JP2000507549A (de)
AT (1) ATE240321T1 (de)
AU (1) AU721867B2 (de)
DE (1) DE69722031T2 (de)
DK (1) DK0954521T3 (de)
ES (1) ES2198567T3 (de)
NO (1) NO984481L (de)
NZ (1) NZ332012A (de)
PT (1) PT954521E (de)
TW (1) TW504512B (de)
WO (1) WO1997035858A1 (de)
ZA (1) ZA972778B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002254265B2 (en) * 1997-12-04 2008-05-15 Allergan, Inc. Imidiazole derivatives and their use as agonists selective at alpha 2B or 2B/2C adrenergic receptors
PT1036065E (pt) * 1997-12-04 2004-09-30 Allergan Inc Derivados de imidazol substituidos com actividade do tipo agonista nos receptores alfa 2b ou 2b/2c adrenergicos
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6426356B1 (en) 1998-11-18 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Imidazoethyl thiophenes
US6465486B1 (en) 1999-03-12 2002-10-15 Ortho-Mcneil Pharmaceutical, Inc. Pyridyl/quinolinyl imidazoles
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
US7893191B2 (en) 2007-02-28 2011-02-22 Corning Incorporated Fused thiophenes, methods for making fused thiophenes, and uses thereof
US7838623B2 (en) 2004-09-14 2010-11-23 Corning Incorporated Fused thiophenes, methods for making fused thiophenes, and uses thereof
KR101206202B1 (ko) 2004-09-14 2012-11-29 코닝 인코포레이티드 융합 티오펜, 융합 티오펜의 제조방법 및 그 용도
RU2448104C2 (ru) * 2005-12-19 2012-04-20 Зингента Лимитед Замещенные ароматические гетероциклические соединения, как фунгициды
EP2155715B1 (de) * 2007-05-14 2013-03-13 Allergan, Inc. ((phenyl)imidazolyl)methylheteroaryl-verbindungen
EP2274310B1 (de) 2008-03-31 2016-05-25 Corning Inc. Kondensierte thiophene und verfahren zu deren herstellung und anwendung
US20130252972A1 (en) * 2010-07-19 2013-09-26 Syngenta Crop Protection Llc Isoxazole, isothiazole, furane and thiophene compounds as microbicides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242571A (ja) * 1988-03-22 1989-09-27 Mitsui Petrochem Ind Ltd イミダゾール誘導体の製造方法
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
WO1992014453A1 (en) * 1991-02-26 1992-09-03 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
US5621113A (en) * 1996-03-28 1997-04-15 Ortho Pharmaceutical Corporation 4-[(thien-2-yl)methyl]-imidazole analgesics

Also Published As

Publication number Publication date
AU721867B2 (en) 2000-07-13
US5750720A (en) 1998-05-12
JP2000507549A (ja) 2000-06-20
ES2198567T3 (es) 2004-02-01
PT954521E (pt) 2003-09-30
ZA972778B (en) 1998-10-01
DK0954521T3 (da) 2003-09-15
DE69722031D1 (en) 2003-06-18
NZ332012A (en) 2000-07-28
AU2422997A (en) 1997-10-17
EP0954521A1 (de) 1999-11-10
EP0954521B1 (de) 2003-05-14
DE69722031T2 (de) 2004-01-29
WO1997035858A1 (en) 1997-10-02
NO984481D0 (no) 1998-09-25
NO984481L (no) 1998-11-23
TW504512B (en) 2002-10-01

Similar Documents

Publication Publication Date Title
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
YU49053B (sh) Fenil heterociklična jedinjenja kao inhibitori ciklooksigenaze-2
DK1052984T3 (da) Antibakterielle midler
ATE228111T1 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
TR200103353T2 (tr) Bir füzyonlu heterosiklik bileşimin hidroklorid tuzu.
ES2188983T3 (es) Nuevas benzofuran-4-carboxamidas.
FI956279L (fi) Menetelmiä ja välituotteita 5-/2-(4-(bentsoisotiatsol-3-yyli)piperatsin-1-yyli)etyyli/-6-kloori-1,3-dihydroindol-2-onin valmistamiseksi
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE250599T1 (de) Benzamidderivate als vasopressin-antagonisten
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
ATE201869T1 (de) 4-((thien-2-yl)methyl)imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
DE60228134D1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
DE69828638D1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
ATE214692T1 (de) Metalloproteinase-inhibitoren
CA2250930A1 (en) 4-[(thien-3-yl)methyl] imidazole derivatives having .alpha.2-adrenoceptor agonistic activity
ATE215935T1 (de) Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0954521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee